Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart’s electrical system. It is considered to be one of the most prevalent types of cardiac arrhythmia. When the heart beats too slowly, too quickly, or irregularly, it is called an arrhythmia. Atrial fibrillation if untreated, can lead to a stroke and other serious medical complications. Atrial fibrillation can be dangerous if a person have diabetes, high blood pressure or other diseases of the heart.
Atrial fibrillation may occur in isolated incidents or it may be a chronic illness, fluttering heartbeat, irregular pulse, weakness, dizziness, and fatigue. Atrial fibrillation is mostly brought on by chaotic signals that cause the atria, the two top chambers of your heart, to contract quickly and out of time. Because of how swiftly they contract, the heart's walls fibrillate. Atrial fibrillation may result from electrical system damage to your heart. The signals in the upper chambers of the heart are disorganized in atrial fibrillation. The outcome is a shaking of the higher chambers (quiver). The lower cardiac chambers are then attempted to be reached by the AV node, which is then inundated with impulses (ventricles). A quick and erratic heart rhythm results from this.
Market Dynamics
High consumption of alcohol is also expected to aid in growth of the market. For instance, according to data published on August 2021, on Gallup, Inc, which is an U.S. analytics and advisory company, stated that about 60% of U.S. adults drink alcoholic beverages in 2021.
Key features of the study:
- This report provides an in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global atrial fibrillation market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd., and Abbott Laboratories.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market
Detailed Segmentation:
- Global Atrial Fibrillation Market, By Procedure:
- Pharmacological
- Anti-arrhythmic
- Anti-coagulant
- Non-Pharmacological
- Catheter Ablation Procedures
- Maze surgery
- Electric Cardioversion
- Global Atrial Fibrillation Market, By Technology:
- Radiofrequency
- Laser
- Cryotherapy
- Others
- Global Atrial Fibrillation Market, By End User:
- Hospitals
- Speciality Clinics
- Others
- Global Atrial Fibrillation Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- AtriCure, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biosense Webster, Inc
- Boehringer Ingelheim GmbH
- Boston Scientific Corporation
- Bristol-Myers Squibb Corporation
- CardioFocus, Inc.
- Endoscopic Technologies, Inc.
- Sanofi Aventis
- Johnson and Johnson Ltd
- Abbott Laboratories
“*” marked represents similar segmentation in other categories in the respective section.
